Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnny Powers Insider Profile
4 Followers
Johnny Powers, EVP at Idexx Laboratories, holds 625.00K shares in Zomedica Pharmaceuticals (Ticker: ZOM), holds 25.96K shares in Idexx Laboratories (Ticker: IDXX). Most recently, Johnny Powers Bought ― shares of Zomedica Pharmaceuticals on Jul 07, 2020 for an estimated value of 100.00K.
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-3.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Johnny Powers holds in companies
Most Profitable Insider Trade
The most profitable trade made by Johnny Powers
Johnny Powers's Trading History
Idexx Laboratories
Dec 08, 2015
EVP
Uninformative Buy
33.79K
$11.79M
Zomedica Pharmaceuticals
Jul 07, 2020
Director
Informative Buy
100.00K
$83.13K
List of latest transactions for each holding click on a transaction to see Johnny Powers's performance on stock
You May Also Like
Johnny Powers insider profile FAQ
What is the percentage of profitable transactions made by Johnny Powers?
The percentage of profitable transactions made by Johnny Powers is 33%.
What is the average return per transaction made by Johnny Powers?
The average return per transaction made by Johnny Powers is -3.50%.
What stocks does Johnny Powers hold?
Johnny Powers holds: IDXX, ZOM stocks.
What was Johnny Powers’s latest transaction?
Johnny Powers latest transaction was an Informative Buy of $100.00K.
What was Johnny Powers's most profitable transaction?
Johnny Powers’s most profitable transaction was an Informative Buy of IDXX stock on March 11, 2015. The return on the trade was 4.20%.
What is Johnny Powers's role in Idexx Laboratories?
Johnny Powers's role in Idexx Laboratories is EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.